通过胎盘转移免疫调节抗体糖基化
Chang Gao1, Qingyan Chen1, Xinxin Hao1
1Department of Blood Transfusion, Shengjing Hospital of China Medical University, Shenyang 110004, China.
International journal of molecular sciences
|December 9, 2023
概括
通过胎盘的母体免疫球蛋白G (IgG) 转移可以保护胎儿. 抗体糖基化显著影响这种转移和胎儿健康,影响新生儿免疫力和孕产妇状况.
科学领域:
- 免疫学 免疫学 免疫学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 葡萄糖生物学 葡萄糖生物学
背景情况:
- 胎盘免疫耐受性对于成功怀孕至关重要.
- 母亲免疫球蛋白G (IgG) 转移可以保护胎儿免受感染.
- 胎盘是怀孕期间免疫调节的关键部位.
研究的目的:
- 在胎盘转移期间审查抗体糖化酶的免疫调节.
- 检查糖化对胎儿健康和新生儿免疫力的影响.
- 探索加强保护性抗体转移和减轻有害抗体的策略.
主要方法:
- 关于胎盘抗体转移机制的文献综述.
- 分析影响IgG运输的因素 (子类,糖化,FcRn介导).
- 研究糖化对抗体功能和转移效率的作用.
主要成果:
- 母体IgG的胎盘转移对于胎儿的保护至关重要.
- 抗体糖基化模式关键调节IgG的转移和功能.
- FcRn介导的传输是一个关键的机制,受pH值和抗体特性的影响.
- 感染和疫苗接种等产妇因素会影响抗体转移.
结论:
- 了解胎盘抗体糖化是优化新生儿免疫的关键.
- 向糖基化可以改善对感染的保护,并管理母亲的自身免疫/非免疫疾病.
- 这些知识有助于制定更健康的怀孕和新生儿的策略.
相关概念视频
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Development of Immunocompetence
312
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
312
Protein Glycosylation
6.9K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.9K
Oligosaccharide Assembly
2.9K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.9K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Hybridoma Technology
14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K


